LYN Antikörper (AA 39-58)
Kurzübersicht für LYN Antikörper (AA 39-58) (ABIN1102916)
Target
Alle LYN Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 39-58
-
Marke
- IHC-plus™
-
Aufreinigung
- Ammonium sulfate precipitation
-
Immunogen
-
Synthetic peptide (a.a. 39-58).
Type of Immunogen: Synthetic peptide -
Isotyp
- IgG2a kappa
-
-
-
-
Applikationshinweise
- Approved: IHC, IHC-P (1:200), IP, WB (1:2000)
-
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- Lot specific
-
Buffer
- HEPES with 0.15M NaCl, 0.01 % BSA, 0.03 % sodium azide, and 50 % glycerol
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
-
Short term: -20°C
Long term: -20°C.
-
-
- LYN (V-Yes-1 Yamaguchi Sarcoma Viral Related Oncogene Homolog (LYN))
-
Andere Bezeichnung
- LYN
-
Hintergrund
-
Name/Gene ID: LYN
Subfamily: Src
Family: Protein Kinase
Synonyms: LYN, Lyn protein tyrosine kinase, Lyn ptk, Lyn tyrosine kinase, p56Lyn, p53Lyn, Tyrosine-protein kinase Lyn, JTK8, Lyn kinase -
Gen-ID
- 4067
-
UniProt
- P07948
-
Pathways
- Fc-epsilon Rezeptor Signalübertragung, Hormone Transport, Response to Growth Hormone Stimulus, Cellular Response to Molecule of Bacterial Origin, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, CXCR4-mediated Signaling Events, Thromboxane A2 Receptor Signaling, Integrin Complex, BCR Signaling
Target
-